Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

692.68 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 25, 2022

Gainers

Via Benzinga

Stocks Pop As "Fear Gauge" Cools Off ↗

October 25, 2022

Stocks have shrugged off premarket losses and are confidently higher ahead of Big Tech earnings.

Via Talk Markets

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗

October 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.

Via Benzinga

Peering Into Medpace Hldgs's Recent Short Interest ↗

October 25, 2022

Medpace Hldgs's (NASDAQ:MEDP) short percent of float has risen 11.68% since its last report. The company recently reported that it has 2.20 million shares sold short, which is 10.52% of all regular...

Via Benzinga

Contract Research Organization Medpace Lifts FY22 Guidance, Highlights FY23 Outlook ↗

October 25, 2022

Via Benzinga

Horror Movies Are Scary Profitable ↗

October 15, 2022

Plus a look at what's happening in the markets and a couple of stocks worth watching.

Via The Motley Fool

Starbucks And 3 Other Stock Insiders Are Buying ↗

September 19, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday ↗

October 25, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Medpace Revises FY22 Outlook On Foreign Exchange Impact ↗

July 26, 2022

Via Benzinga

$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today ↗

October 25, 2022

Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.08% on an annualized basis producing an average annual return of 43.37%. Currently, Medpace Hldgs has a market...

Via Benzinga

US Stocks Open Higher; Dow Rises Over 100 Points ↗

October 25, 2022

U.S. stocks traded higher this morning, with the Dow Jones surging more than 100 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 25, 2022

Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.

Via Benzinga

Medpace Holdings, Inc. Reports Third Quarter 2022 Results

October 24, 2022

From Medpace Holdings, Inc.

Via Business Wire

Preview: Medpace Hldgs's Earnings ↗

October 21, 2022

Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-10-24. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs...

Via Benzinga

Earnings Scheduled For October 24, 2022 ↗

October 24, 2022

Companies Reporting Before The Bell • Imperial Ptrl (NASDAQ:IMPP) is likely to report earnings for its third quarter.

Via Benzinga

Medpace Holdings, Inc. to Report Third Quarter 2022 Financial Results on October 24, 2022

September 27, 2022

From Medpace Holdings, Inc.

Via Business Wire

Adobe And 2 Other Stock Insiders Are Buying ↗

September 26, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Around $30 Million Bet On Medpace Holdings? 3 Stocks Insiders Are Buying ↗

September 23, 2022

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

$10 Million Bet On NortonLifeLock? 4 Stocks Insiders Are Buying ↗

September 21, 2022

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Over $29 Million Bet On Energy Transfer? 3 Stocks Insiders Are Buying ↗

September 13, 2022

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Around $17 Million Bet On This Healthcare Stock? 4 Stocks Insiders Are Buying ↗

September 09, 2022

Although US stocks closed higher on Thursday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

Medpace Holdings, Inc. Reports Second Quarter 2022 Results

July 25, 2022

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For July 25, 2022 ↗

July 25, 2022

Companies Reporting Before The Bell • Lakeland Financial (NASDAQ:LKFN) is estimated to report quarterly earnings at $0.95 per share on revenue of $59.26 million.

Via Benzinga

Earnings Outlook For Medpace Hldgs ↗

July 22, 2022

Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs...

Via Benzinga

$1.4 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying ↗

July 21, 2022

Although US stocks closed higher on Wednesday, there were a few notable insider trades.

Via Benzinga

Medpace Holdings, Inc. to Report Second Quarter 2022 Financial Results on July 25, 2022

July 07, 2022

From Medpace Holdings, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗

May 24, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.